Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Research & Development (2024 - 2025)

Beta Bionics' Research & Development history spans 2 years, with the latest figure at $10.1 million for Q4 2025.

  • For Q4 2025, Research & Development rose 9.95% year-over-year to $10.1 million; the TTM value through Dec 2025 reached $34.8 million, up 32.86%, while the annual FY2025 figure was $34.8 million, 32.86% up from the prior year.
  • Research & Development for Q4 2025 was $10.1 million at Beta Bionics, up from $8.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $10.1 million in Q4 2025 and bottomed at $5.1 million in Q3 2024.